Tag: Novartis trials new drug that delays breast cancer progression

Novartis trials new drug that delays breast cancer progression

December 9, 2019

A breast cancer diagnosis is usually distressing to patients across all age groups, especially for the younger ones who have much of life to experience. In fact, advanced breast cancer (ABC) in pre-menopausal women is more aggressive– it is the leading cause of cancer death in women aged 20–59 years old. Pharmaceutical conglomerate Novartis has recognised […]

Continue Reading